Ideal P2Y12 Inhibitor in Acute Coronary Syndrome: A Review and Current Status

Dual antiplatelet therapy (DAPT) has remained the cornerstone for management of acute coronary syndrome (ACS) over the years. Clopidogrel has been the quintessential P2Y12 receptor (platelet receptor for Adenosine 5′ diphosphate) inhibitor for the past two decades. With the demonstration of unequivo...

Descripción completa

Detalles Bibliográficos
Autores principales: Pradhan, Akshyaya, Tiwari, Aashish, Caminiti, Giuseppe, Salimei, Chiara, Muscoli, Saverio, Sethi, Rishi, Perrone, Marco Alfonso
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9331944/
https://www.ncbi.nlm.nih.gov/pubmed/35897347
http://dx.doi.org/10.3390/ijerph19158977

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9331944/
https://www.ncbi.nlm.nih.gov/pubmed/35897347
http://dx.doi.org/10.3390/ijerph19158977

Ejemplares similares